Molecular Dynamics Simulation of The Free and Inhibitor Bound Kras Pde Systems Insights on The Inhibition Mechanism
ESPA 2016, 28 Haziran 2016
BOZ ESRA,TÜZÜN NURCAN,DURDAĞI SERDAR
|
IN-SILICO SCREENING OF DRP1 INHIBITOR MOLECULES BY TAKING THE FLEXIBILITY OF DRP1 PROTEIN INTO ACCOUNT
Bilişim Enstitüsü, İstanbul Teknik Üniversitesi, 2024
ESRA BARDAKCI
|
The efficacy of angiotensin-converting enzyme inhibitors in preventing postoperative tendon adhesion formation: An experimental study in rats
ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA, Vol. 56, No. 1, Ocak 2022, s. 1-7, ISSN: 1017-995X
YASAK TUĞÇE, ÖZKAYA ÖZAY, ŞAHİN AYÇA ERGAN, AKSU SAYMAN ÖZDEN, BOZDAĞ SÜREYYA ERGÜN
|
An easy route for preparation of carboxylic acid and urea functional block copolymer as corrosion inhibitor
Informa UK Limited, Ağustos 2023, ISSN: 0169-4243
İNCE AHMET, KORAMAZ İLAYDA, KAYA ERTUĞRUL, KARAGÖZ BÜNYAMİN
|
Electrochemical Nanosensor Development for the Determination of VEGFR Tyrosine Kinase Inhibitor Drug Axitinib
PBA2023, 33rd International Symposium on Pharmaceutical and Biomedical Analysis Abstracts and Proceedings, Ankara/TÜRKİYE, 2 Temmuz 2023, s. 155-156
ÇETİNKAYA AHMET, KAYA SARİYE İREM, PELİN ŞENEL, ÇİNİ NEJLA, B. ATİCİ ESEN, ÖZKAN SİBEL AYŞIL, YURTSEVER MİNE, GÖLCÜ AYŞEGÜL
|
A novel BH3 mimetic Bcl-2 inhibitor promotes autophagic cell death and reduces in vivo Glioblastoma tumor growth
Springer Science and Business Media LLC, Vol. 8, Ekim 2022, ISSN: 2058-7716
CALİS SEYMA, DOĞAN BERNA, DURDAĞI SERDAR, CELEBİ CELEBİ, YAPICIER ÖZLEM, KILIÇ TÜRKER, TAHİR TURANLI EDA, AVŞAR TİMUÇİN
|
Spectroscopic, electrochemical, and some theoretical studies on the interactional of neuraminidase inhibitor zanamivir with double helix deoxyribonucleic acid
Journal of Molecular Structure, Vol. 1262, Ocak 2022, ISSN: 0022-2860
ŞENEL PELİN, ÇETİNKAYA AHMET, ÇETİNKAYA AHMET, KAYA S. İREM, ERDOĞAN TANER, DOĞAN TOPAL BURCU, GÖLCÜ AYŞEGÜL, ÖZKAN SİBEL AYŞIL
|
Yeni MDM2 ve TrkA Hit İnhibitör Moleküllerin Çok Boyutlu Moleküler Modelleme Yaklaşımları ile Belirlenmesi
3. Hesaplamalı Kimya Kongresi, Ankara/TÜRKİYE, 12 Ekim 2017
AYDIN GÜLŞAH,YURTSEVER MİNE,DURDAĞI SERDAR
|
A COMPUTATIONAL STUDY ON POTENTIAL NEW INHIBITORS OF OACETYLPEPTIDOGLYCAN ESTERASE
11EuCOTCC (11 European Conference on Theoretical and Computational Chemistry, 4 Eylül 2017
TATAROĞLU MUAMMER MELİN,AKSAKAL ZEYNEP,TÜZÜN NURCAN,SUNGUR FETHİYE AYLİN
|
Heterotopologic Third Space as Inhibitor Factor of Gentrification
From CONTESTED_CITIES to global urban justice - critical dialogues, Madrid/İSPANYA, 4 Temmuz 2016, s. 1-10
BÜYÜKTOPCU ERENALP
|
A COMPUTATIONAL STUDY ON POTENTIAL NEW INHIBITORS OF OACETYLPEPTIDOGLYCAN ESTERASE
11EuCOTCC (11 European Conference on Theoretical and Computational Chemistry, 4 Eylül 2017
TATAROĞLU MUAMMER MELİN,AKSAKAL ZEYNEP,TÜZÜN NURCAN,SUNGUR FETHİYE AYLİN
|
Novel high throughput screen identifies an HIV 1 reverse transcriptase inhibitor with a unique mechanism of action
Biochemical Journal, Vol. 462, No. 3, Eylül 2014, s. 425-432, ISSN: 0264-6021
SHEEN CHİH WEİ, ALPTÜRK ONUR, SLUİSCREMER NİCOLAS
|
In silico methods predict new blood-brain barrier permeable structure for the inhibition of kynurenine 3-monooxygenase
JOURNAL OF MOLECULAR GRAPHICS MODELLING, Vol. 100, No. null, Kasım 2020, ISSN: 1093-3263
ÖZKILIÇ YILMAZ,TÜZÜN NURCAN
|
A NOVEL MAO-B INHIBITOR DRG-MAOB-1 FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES
Patent No: US-20230093302-A1, Patent Sınıfı: A1, 2023
SERDAR DURDAGİ,MİNE YURTSEVER,BUSECAN SERHAT AKSOYDAN, MURAT SENTURK
|
DRG-MDM2-6 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR
Patent No: US-20230098888-A1, Patent Sınıfı: A1, 2023
MİNE YURTSEVER, MUGE DİDEM ORHAN, MAİDE NUR PAKSOY, GULSAH AYDİN, TİMUCİN AVSAR, SERDAR DURDAGİ
|
Drg-mdm2-5 for use as a novel mouse double minute 2 (mdm2) inhibitor
Patent No: US-20230063449-A1, Patent Sınıfı: A1, 2023
SERDAR DURDAGİ, TİMUCİN AVSAR, MİNE YURTSEVER, GULSAH AYDİN, MAİDE NUR PAKSOY, MUGE DİDEM ORHAN
|
Drg-mdm2-3 for use as a novel mouse double minute 2 (mdm2) inhibitor
Patent No: US-20230067644-A1, Patent Sınıfı: A1, 2023
SERDAR DURDAGİ, MUGE ORHAN, TİMUCİN AVSAR, MAİDE PAKSOY, GULSAH AYDİN, MİNE YURTSEVER
|
DRG-MDM2-1 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR
Patent No: US-20230073261-A1, Patent Sınıfı: A1, 2023
SERDAR DURDAGİ, TİMUCİN AVSAR, MUGE DİDEM ORHAN, MAİDE NUR PAKSOY, GULSAH AYDİN, MİNE YURTSEVER
|
A NOVEL SELECTIVE MAO-B INHIBITOR DRG-MAOB-2 FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES
Patent No: US-20230088611-A1, Patent Sınıfı: A1, 2023
SERDAR DURDAĞI, MİNE YURTSEVER,BUSECAN AKSOYDAN, MURAT SENTURK
|
DRG-MDM2-4 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR
Patent No: US-20230071340-A1, Patent Sınıfı: A1, 2023
TİMUCİN AVSAR, SERDAR DURDAGİ, MUGE DİDEM ORHAN, MAİDE NUR PAKSOY, GULSAH AYDİN, MİNE YURTSEVER
|